These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16768633

  • 1. Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.
    Saxena K, Howe M, Simeonova D, Steiner H, Chang K.
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):252-9. PubMed ID: 16768633
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM.
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [Abstract] [Full Text] [Related]

  • 3. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE, Kowatch RA, Carmody T, Rush AJ.
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [Abstract] [Full Text] [Related]

  • 4. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T, Hirsch L, Gardner D, Gorman DA.
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [Abstract] [Full Text] [Related]

  • 5. Combination lithium and divalproex sodium in pediatric bipolarity.
    Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR.
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):895-901. PubMed ID: 12874490
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    Blader JC, Schooler NR, Jensen PS, Pliszka SR, Kafantaris V.
    Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms.
    Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H.
    J Clin Psychiatry; 2003 Aug; 64(8):936-42. PubMed ID: 12927009
    [Abstract] [Full Text] [Related]

  • 16. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF, Paulsson B, Brecher M.
    J Affect Disord; 2007 Aug; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Aug; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.